SYK is a novel target for treatment of Epstein Barr virus-infected B cell lymphomas in post-transplant lymphoproliferative disease. 7th American Transplant Congress Hatton, O., Vaysberg, M., Sharman, J., Krams, S. M., Esquivel, C. O., Martinez, O. M. WILEY-BLACKWELL. 2007: 317–318

View details for Web of Science ID 000246370201087